Inventor · disambiguated record
Henry Lu
Also filed as: LU HENRY · LU HENRY H
14 granted patents·8 pending applications·227 citations·filing 2002–2024
92Inventor score
Top patents by PatentIndex Score
22 records- 0195US8462332B2Multi-layer slides for analysis of urine sedimentsPUGIA MICHAEL J·Filed 2009·Granted Jun 11, 2013·39 cites·17 claims
- 0294US7153880B2Substituted diphenyl heterocycles useful for treating HCV infectionRIGEL PHARMACEUTICALS INC·Filed 2004·Granted Dec 26, 2006·68 cites·15 claims
- 0393US6759538B2Substituted diphenyl heterocycles useful for treating HCV infectionRIGEL PHARMACEUTICALS INC·Filed 2002·Granted Jul 6, 2004·71 cites·34 claims
- 0486US7569580B2Heterotricyclic compounds for use as HCV inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2005·Granted Aug 4, 2009·6 cites·11 claims
- 0583US6927031B2Methods for identifying polypeptide factors interacting with RNARIGEL PHARMACEUTICALS INC·Filed 2002·Granted Aug 9, 2005·13 cites·63 claims
- 0681US7332602B2Pyridyl substituted heterocycles useful for treating or preventing HCV infectionRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Feb 19, 2008·3 cites·27 claims
- 0781US7157473B2Pyridyl substituted heterocycles useful for treating or preventing HCV infectionRIGEL PHARMACEUTICALS INC·Filed 2003·Granted Jan 2, 2007·12 cites·57 claims
- 0880US7132234B2Methods and compositions for the identification of anti-poxvirus agentsRIGEL PHARMACEUTICALS INC·Filed 2004·Granted Nov 7, 2006·6 cites·32 claims
- 0975US7776847B2Benzisothiazoles useful for treating or preventing HCV infectionRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Aug 17, 2010·3 cites·5 claims
- 1073US7498353B2Heterocyclic anti-viral compounds comprising metabolizable moieties and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Mar 3, 2009·2 cites·24 claims
- 1173US7410979B2Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infectionsRIGEL PHARMACEUTICALS INC·Filed 2004·Granted Aug 12, 2008·4 cites·16 claims
- 1261US7714137B2Pyridyl substituted heterocycles useful for treating or preventing HCV infectionRIGEL PHARMACEUTICALS INC·Filed 2007·Granted May 11, 2010·0 cites·1 claims
- 1359US2024382333A1Joint alignment device for improved mobility and functionLU HENRY·Filed 2024·Application pending·0 cites
- 1453US2005009877A1Methods of identifying HCV NS5B polymerase inhibitors and their usesFiled 2004·Application pending·0 cites
- 1551US7358259B2HCV inhibitors and methods of using themRIGEL PHARMACEUTICALS INC·Filed 2004·Granted Apr 15, 2008·0 cites·18 claims
- 1650US2007149520A1HCV Inhibitors And Methods Of Using ThemRIGEL PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1745US7514434B2Heterocyclic compounds having an oxadiazole moiety and hydro isomers thereofRIGEL PHARMACEUTICALS INC·Filed 2005·Granted Apr 7, 2009·0 cites·12 claims
- 1845US2005143433A1Substituted heterocycles useful for treating HCV infectionFiled 2004·Application pending·0 cites
- 1945US2005215614A1Substituted indoles and their use as hcv inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 2041US2005239751A1Heterocyclic anti-viral compounds comprising metabolizable moieties and their usesRIGEL PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 2140US2013041236A1Sample analysis system and method of useSIEMENS HEALTHCARE DIAGNOSTICS·Filed 2011·Application pending·0 cites
- 2239US2003219723A1Compositions and methods for screening and identifying anti-HCV agentsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Henry Lu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →